HISTABIOSONE
HISTABIOSONE
Authorised
- Dexamethasone
- Chlorphenamine maleate
- Benzylpenicillin procaine monohydrate
- Dihydrostreptomycin sulfate
Product identification
Medicine name:
HISTABIOSONE
Active substance:
- Dexamethasone
- Chlorphenamine maleate
- Benzylpenicillin procaine monohydrate
- Dihydrostreptomycin sulfate
Target species:
-
Cattle
-
Pig
-
Goat
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Dexamethasone0.50milligram(s)1.00millilitre(s)
-
Chlorphenamine maleate10.00milligram(s)1.00millilitre(s)
-
Benzylpenicillin procaine monohydrate200.00milligram(s)1.00millilitre(s)
-
Dihydrostreptomycin sulfate312.90milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
-
Meat and offal30day
-
Milk5day
-
- Pig
-
Meat and offal30day
-
- Goat
-
Milk5day
-
Meat and offal30day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RV01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
- Trirx Segre
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/7978797 4/1988
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?: